Concentric Wealth Management, LLC Amgen Inc Transaction History

Concentric Wealth Management, LLC

$473 Million
Q3 2024

A detailed history of Concentric Wealth Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Concentric Wealth Management, LLC holds 26,025 shares of AMGN stock, worth $7.67 Million. This represents 1.77% of its overall portfolio holdings.

Number of Shares

26,025

Previous 26,275 0.95%

Holding current value

$7.67 Million

Previous $8.21 Million 2.14%

% of portfolio

1.77%

Previous 2.16%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$309.38 - $337.38 $77,345 - $84,345	-250 Reduced 0.95%	26,025 $8.39 Million
Q2 2024 Aug 13, 2024	BUY	$262.75 - $319.31 $88,546 - $107,607	337 Added 1.3%	26,275 $8.21 Million
Q1 2024 May 08, 2024	BUY	$268.87 - $324.56 $100,826 - $121,710	375 Added 1.47%	25,938 $7.37 Million
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $22,245 - $25,096	87 Added 0.34%	25,563 $7.36 Million
Q3 2023 Nov 08, 2023	BUY	$218.65 - $271.46 $61,222 - $76,008	280 Added 1.11%	25,476 $6.85 Million
Q2 2023 Aug 08, 2023	BUY	$214.27 - $253.37 $224,983 - $266,038	1,050 Added 4.35%	25,196 $5.59 Million
Q1 2023 May 10, 2023	BUY	$225.79 - $275.2 $36,352 - $44,307	161 Added 0.67%	24,146 $5.84 Million
Q4 2022 Feb 10, 2023	SELL	$229.03 - $291.01 $278,958 - $354,450	-1,218 Reduced 4.83%	23,985 $6.3 Million
Q3 2022 Nov 09, 2022	BUY	$224.46 - $253.15 $8,080 - $9,113	36 Added 0.14%	25,203 $5.68 Million
Q2 2022 Aug 12, 2022	SELL	$230.71 - $256.74 $26,762 - $29,781	-116 Reduced 0.46%	25,167 $6.12 Million
Q1 2022 Apr 14, 2022	BUY	$219.27 - $242.57 $81,129 - $89,750	370 Added 1.49%	25,283 $6.11 Million
Q4 2021 Feb 10, 2022	BUY	$198.88 - $227.6 $140,210 - $160,458	705 Added 2.91%	24,913 $5.61 Million
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $117,809 - $138,028	555 Added 2.35%	24,208 $5.15 Million
Q2 2021 Aug 12, 2021	BUY	$233.58 - $259.14 $156,265 - $173,364	669 Added 2.91%	23,653 $5.77 Million
Q1 2021 May 14, 2021	BUY	$221.91 - $258.6 $246,098 - $286,787	1,109 Added 5.07%	22,984 $5.72 Million
Q4 2020 Feb 10, 2021	BUY	$216.38 - $257.67 $73,569 - $87,607	340 Added 1.58%	21,875 $5.03 Million
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $27,454 - $30,531	117 Added 0.55%	21,535 $5.47 Million
Q2 2020 Aug 11, 2020	BUY	$197.81 - $242.74 $47,474 - $58,257	240 Added 1.13%	21,418 $5.05 Million
Q1 2020 May 07, 2020	BUY	$182.24 - $241.7 $15,490 - $20,544	85 Added 0.4%	21,178 $4.29 Million
Q4 2019 Feb 10, 2020	BUY	$189.21 - $243.2 $1.33 Million - $1.7 Million	7,009 Added 49.77%	21,093 $5.09 Million
Q3 2019 Nov 06, 2019	BUY	$174.11 - $208.62 $9,053 - $10,848	52 Added 0.37%	14,084 $2.73 Million
Q2 2019 Aug 05, 2019	BUY	$166.7 - $195.41 $80,849 - $94,773	485 Added 3.58%	14,032 $2.59 Million
Q1 2019 May 08, 2019	BUY	$180.87 - $203.88 $100,382 - $113,153	555 Added 4.27%	13,547 $2.57 Million
Q4 2018 Feb 13, 2019	BUY	$178.4 - $208.25 $158,776 - $185,342	890 Added 7.35%	12,992 $2.53 Million
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $39,096 - $44,075	-211 Reduced 1.71%	12,102 $2.51 Million
Q2 2018 Aug 06, 2018	BUY	$166.05 - $186.51 $101,290 - $113,771	610 Added 5.21%	12,313 $2.27 Million
Q1 2018 May 03, 2018	BUY	$169.43 - $198.0 $48,287 - $56,430	285 Added 2.5%	11,703 $2 Million
Q4 2017 Feb 06, 2018	BUY	$168.79 - $188.59 $57,051 - $63,743	338 Added 3.05%	11,418 $1.99 Million
Q3 2017 Nov 07, 2017	BUY	$167.29 - $191.0 $1.85 Million - $2.12 Million	11,080	11,080 $2.07 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concentric Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Concentric Wealth Management, LLC with notifications on news.

Account

Concentric Wealth Management, LLC Amgen Inc Transaction History